KCNQ1 Polymorphism in the Context of Ischemic Cardiomyopathy: A Potential Key to Decision‐Making for Device Implantation
Clinical Cardiology · 2025
DOI: 10.1002/clc.70148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2025. Verfasst von Uğur Özkan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, School of Medicine, Trakya University, Turkey. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Myocardial Ischemia, KCNQ1 Potassium Channel, Tachycardia, Ventricular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by the Scientific Research Projects of Trakya University (Project No: 2022/210)..
Abstract (Originalsprache)
Background
Ventricular tachyarrhythmia (VTA) in ischemic cardiomyopathy (ICM) is a life‐threatening condition influenced by genetic factors and electrical remodeling. This study investigated the association between KCNQ1 gene polymorphisms (rs2237892 and rs2237895) and the development of VTA in ICM patients to improve risk stratification and guide device implantation decisions.
Methods
This single‐center study included 213 ICM patients with implantable cardioverter‐defibrillators (ICD) for primary prevention of VTA. Patients were divided into arrhythmia and control groups based on device interrogation findings. Genetic analysis for rs2237892 and rs2237895 polymorphisms was performed using real‐time polymerase chain reaction (PCR). Clinical, electrocardiographic, and laboratory parameters were analyzed. Correlation and logistic regression analyses evaluated the association between KCNQ1 polymorphisms and VTA risk.
Results
The arrhythmia group demonstrated significantly higher QT dispersion, frontal QRS‐T angle, and T‐wave peak‐to‐end interval compared to the control group. The TT genotype of rs2237892 and the AC genotype of rs2237895 were significantly associated with increased VTA risk ( p < 0.001). Multivariate analysis confirmed these genotypes as independent predictors of VTA. No significant differences in other clinical or laboratory risk factors were observed.
Conclusions
KCNQ1 gene polymorphisms (rs2237892 and rs2237895) are strongly associated with VTA in ICM patients, suggesting a potential role as biomarkers for risk stratification. These findings may assist in tailoring ICD implantation decisions and improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, School of Medicine, Trakya University, Turkey.
- Department of Biophysics, Faculty of Medicine, Trakya University, Turkey.
- Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Trakya University, Turkey.
ORCID-Profile: Uğur Özkan, Metin Budak, Muhammet Gürdoğan, Gülnur Öztürk, Mustafa Yildiz, Gökay Taylan, Servet Altay, Kenan Yalta
Förderung
- This study was supported by the Scientific Research Projects of Trakya University (Project No: 2022/210).
Zitieren
APA
Özkan, U., Budak, M., Gürdoğan, M., Öztürk, G., Yildiz, M., Taylan, G., Altay, S., & Yalta, K. (2025). KCNQ1 Polymorphism in the Context of Ischemic Cardiomyopathy: A Potential Key to Decision‐Making for Device Implantation. Clinical Cardiology. https://doi.org/10.1002/clc.70148
Vancouver
Özkan U, Budak M, Gürdoğan M, Öztürk G, Yildiz M, Taylan G, et al. KCNQ1 Polymorphism in the Context of Ischemic Cardiomyopathy: A Potential Key to Decision‐Making for Device Implantation. Clinical Cardiology. 2025. doi:10.1002/clc.70148
BibTeX
@article{zkan2025,
author = {Özkan, Uğur and Budak, Metin and Gürdoğan, Muhammet and Öztürk, Gülnur and Yildiz, Mustafa and Taylan, Gökay and Altay, Servet and Yalta, Kenan},
title = {KCNQ1 Polymorphism in the Context of Ischemic Cardiomyopathy: A Potential Key to Decision‐Making for Device Implantation},
journal = {Clinical Cardiology},
year = {2025},
doi = {10.1002/clc.70148}
}
EUVIMED